Market Research

Pharmaceutical Testing and Analytical Services Market (Service Type: Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Stability Testing, Microbial Testing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, a

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 195 Pages Transparency Market Research Pvt. Ltd. March, 2024 TNPR18769931
Best Price Guarantee
Price from $5,795
Length 195 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date March, 2024
SKU TNPR18769931

Pharmaceutical Testing and Analytical Services Market (Service Type: Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Stability Testing, Microbial Testing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Pharmaceutical Testing and Analytical Services Market – Scope of Report

TMR’s report on the global pharmaceutical testing and analytical services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global pharmaceutical testing and analytical services market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pharmaceutical testing and analytical services market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical testing and analytical services market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pharmaceutical testing and analytical services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pharmaceutical testing and analytical services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pharmaceutical testing and analytical services market.

The report delves into the competitive landscape of the global pharmaceutical testing and analytical services market. Key players operating in the global pharmaceutical testing and analytical services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pharmaceutical testing and analytical services market profiled in this report.

Key Questions Answered in Global pharmaceutical testing and analytical services Market Report
  • What is the sales/revenue generated by pharmaceutical testing and analytical services across all regions during the forecast period?
  • What are the opportunities in the global pharmaceutical testing and analytical services market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Pharmaceutical Testing and Analytical Services Market – Research Objectives and Research Approach

The comprehensive report on the global pharmaceutical testing and analytical services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pharmaceutical testing and analytical services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical testing and analytical services market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pharmaceutical Testing and Analytical Services Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by Service Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Service Type, 2020-2034
6.3.1. Bioanalytical Testing
6.3.1.1. Cell-based Assays
6.3.1.2. Virology Testing
6.3.1.3. Others
6.3.2. Method Development & Validation
6.3.2.1. Extractables & Leachables Method Development and Validation
6.3.2.2. Stability-indicating Method Validation
6.3.2.3. Process Impurity Method Development & Validation
6.3.2.4. Others
6.3.3. Raw Material Testing
6.3.3.1. Heavy Metal Testing
6.3.3.2. Complete Compendial Testing
6.3.3.3. Others
6.3.4. Stability Testing
6.3.4.1. Drug Substance Stability Testing
6.3.4.2. Formulation Evaluation Stability Testing
6.3.4.3. Others
6.3.5. Microbial Testing
6.3.5.1. Microbial Limit Testing
6.3.5.2. Sterility Testing
6.3.5.3. Endotoxin Testing
6.3.5.4. Others
6.3.6. Others
6.4. Market Attractiveness Analysis, by Service Type
7. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2020-2034
7.3.1. Medical Device Companies
7.3.2. Pharmaceutical & Biopharmaceutical Companies
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Pharmaceutical Testing and Analytical Services Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Service Type, 2020-2034
9.3.1. Bioanalytical Testing
9.3.1.1. Cell-based Assays
9.3.1.2. Virology Testing
9.3.1.3. Others
9.3.2. Method Development & Validation
9.3.2.1. Extractables & Leachables Method Development and Validation
9.3.2.2. Stability-indicating Method Validation
9.3.2.3. Process Impurity Method Development & Validation
9.3.2.4. Others
9.3.3. Raw Material Testing
9.3.3.1. Heavy Metal Testing
9.3.3.2. Complete Compendial Testing
9.3.3.3. Others
9.3.4. Stability Testing
9.3.4.1. Drug Substance Stability Testing
9.3.4.2. Formulation Evaluation Stability Testing
9.3.4.3. Others
9.3.5. Microbial Testing
9.3.5.1. Microbial Limit Testing
9.3.5.2. Sterility Testing
9.3.5.3. Endotoxin Testing
9.3.5.4. Others
9.3.6. Others
9.4. Market Value Forecast, by End-user, 2020-2034
9.4.1. Medical Device Companies
9.4.2. Pharmaceutical & Biopharmaceutical Companies
9.4.3. Others
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Service Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Service Type, 2020-2034
10.3.1. Bioanalytical Testing
10.3.1.1. Cell-based Assays
10.3.1.2. Virology Testing
10.3.1.3. Others
10.3.2. Method Development & Validation
10.3.2.1. Extractables & Leachables Method Development and Validation
10.3.2.2. Stability-indicating Method Validation
10.3.2.3. Process Impurity Method Development & Validation
10.3.2.4. Others
10.3.3. Raw Material Testing
10.3.3.1. Heavy Metal Testing
10.3.3.2. Complete Compendial Testing
10.3.3.3. Others
10.3.4. Stability Testing
10.3.4.1. Drug Substance Stability Testing
10.3.4.2. Formulation Evaluation Stability Testing
10.3.4.3. Others
10.3.5. Microbial Testing
10.3.5.1. Microbial Limit Testing
10.3.5.2. Sterility Testing
10.3.5.3. Endotoxin Testing
10.3.5.4. Others
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Medical Device Companies
10.4.2. Pharmaceutical & Biopharmaceutical Companies
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Service Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Service Type, 2020-2034
11.3.1. Bioanalytical Testing
11.3.1.1. Cell-based Assays
11.3.1.2. Virology Testing
11.3.1.3. Others
11.3.2. Method Development & Validation
11.3.2.1. Extractables & Leachables Method Development and Validation
11.3.2.2. Stability-indicating Method Validation
11.3.2.3. Process Impurity Method Development & Validation
11.3.2.4. Others
11.3.3. Raw Material Testing
11.3.3.1. Heavy Metal Testing
11.3.3.2. Complete Compendial Testing
11.3.3.3. Others
11.3.4. Stability Testing
11.3.4.1. Drug Substance Stability Testing
11.3.4.2. Formulation Evaluation Stability Testing
11.3.4.3. Others
11.3.5. Microbial Testing
11.3.5.1. Microbial Limit Testing
11.3.5.2. Sterility Testing
11.3.5.3. Endotoxin Testing
11.3.5.4. Others
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Medical Device Companies
11.4.2. Pharmaceutical & Biopharmaceutical Companies
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Service Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Service Type, 2020-2034
12.3.1. Bioanalytical Testing
12.3.1.1. Cell-based Assays
12.3.1.2. Virology Testing
12.3.1.3. Others
12.3.2. Method Development & Validation
12.3.2.1. Extractables & Leachables Method Development and Validation
12.3.2.2. Stability-indicating Method Validation
12.3.2.3. Process Impurity Method Development & Validation
12.3.2.4. Others
12.3.3. Raw Material Testing
12.3.3.1. Heavy Metal Testing
12.3.3.2. Complete Compendial Testing
12.3.3.3. Others
12.3.4. Stability Testing
12.3.4.1. Drug Substance Stability Testing
12.3.4.2. Formulation Evaluation Stability Testing
12.3.4.3. Others
12.3.5. Microbial Testing
12.3.5.1. Microbial Limit Testing
12.3.5.2. Sterility Testing
12.3.5.3. Endotoxin Testing
12.3.5.4. Others
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Medical Device Companies
12.4.2. Pharmaceutical & Biopharmaceutical Companies
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Service Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Service Type, 2020-2034
13.3.1. Bioanalytical Testing
13.3.1.1. Cell-based Assays
13.3.1.2. Virology Testing
13.3.1.3. Others
13.3.2. Method Development & Validation
13.3.2.1. Extractables & Leachables Method Development and Validation
13.3.2.2. Stability-indicating Method Validation
13.3.2.3. Process Impurity Method Development & Validation
13.3.2.4. Others
13.3.3. Raw Material Testing
13.3.3.1. Heavy Metal Testing
13.3.3.2. Complete Compendial Testing
13.3.3.3. Others
13.3.4. Stability Testing
13.3.4.1. Drug Substance Stability Testing
13.3.4.2. Formulation Evaluation Stability Testing
13.3.4.3. Others
13.3.5. Microbial Testing
13.3.5.1. Microbial Limit Testing
13.3.5.2. Sterility Testing
13.3.5.3. Endotoxin Testing
13.3.5.4. Others
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Medical Device Companies
13.4.2. Pharmaceutical & Biopharmaceutical Companies
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Service Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. Eurofins Scientific
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Laboratory Corporation of America Holdings
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Charles River Laboratories International, Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. SGS S.A.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Intertek Group plc
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. RD laboratories, Inc.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Wuxi AppTec Co., Ltd.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. DYNALABS LLC (Infinity Laboratories)
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. ARL Bio Pharma
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings